These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 12502983)

  • 41. The onset time of atracurium is prolonged in patients with sickle cell disease.
    Dulvadestin P; Gilton A; Hernigou P; Marty J
    Anesth Analg; 2008 Jul; 107(1):113-6. PubMed ID: 18635475
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cisatracurium pharmacokinetics and pharmacodynamics during hypothermic cardiopulmonary bypass in infants and children.
    Withington D; Ménard G; Varin F
    Paediatr Anaesth; 2011 Mar; 21(3):341-6. PubMed ID: 21223452
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Atracurium during thoracic surgery: impaired efficiency in septic processes.
    Knüttgen D; Jahn M; Zeidler D; Doehn M
    J Cardiothorac Vasc Anesth; 1999 Feb; 13(1):26-9. PubMed ID: 10069279
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Influence of extreme obesity on the body disposition and neuromuscular blocking effect of atracurium.
    Varin F; Ducharme J; Théorêt Y; Besner JG; Bevan DR; Donati F
    Clin Pharmacol Ther; 1990 Jul; 48(1):18-25. PubMed ID: 2369806
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Distinct pharmacologic properties of neuromuscular blocking agents on human neuronal nicotinic acetylcholine receptors: a possible explanation for the train-of-four fade.
    Jonsson M; Gurley D; Dabrowski M; Larsson O; Johnson EC; Eriksson LI
    Anesthesiology; 2006 Sep; 105(3):521-33. PubMed ID: 16931985
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of neuromuscular block of atracurium and rocuronium in adults.
    Hans P; Brichant JF; Franzen A; Faleres X; Lamy M
    Acta Anaesthesiol Belg; 1996; 47(2):53-8. PubMed ID: 8869671
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of isoflurane and sevoflurane on the magnitude and time course of neuromuscular block produced by vecuronium, pancuronium and atracurium.
    Vanlinthout LE; Booij LH; van Egmond J; Robertson EN
    Br J Anaesth; 1996 Mar; 76(3):389-95. PubMed ID: 8785139
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical pharmacology of mivacurium chloride (BW B1090U) infusion: comparison with vecuronium and atracurium.
    Ali HH; Savarese JJ; Embree PB; Basta SJ; Stout RG; Bottros LH; Weakly JN
    Br J Anaesth; 1988 Nov; 61(5):541-6. PubMed ID: 2905143
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Interactions between mivacurium and atracurium.
    Naguib M; Abdulatif M; al-Ghamdi A; Selim M; Seraj M; el-Sanbary M; Magboul MA
    Br J Anaesth; 1994 Oct; 73(4):484-9. PubMed ID: 7999489
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Up-regulation of acetylcholine receptors during subchronic infusion of pancuronium is caused by a posttranscriptional mechanism related to disuse.
    Fink H; Yasuhara S; Blobner M; Martyn JA
    Crit Care Med; 2004 Feb; 32(2):509-13. PubMed ID: 14758171
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of chronic sepsis on contractile properties of fast twitch muscle in an experimental model of critical illness neuromyopathy in the rat.
    Rossignol B; Gueret G; Pennec JP; Morel J; Rannou F; Giroux-Metges MA; Talarmin H; Gioux M; Arvieux CC
    Crit Care Med; 2008 Jun; 36(6):1855-63. PubMed ID: 18520643
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cross-resistance to both atracurium- and vecuronium-induced neuromuscular blockade in a critically ill patient.
    Fish DN; Singletary TJ
    Pharmacotherapy; 1997; 17(6):1322-7. PubMed ID: 9399619
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cellular mechanisms of atracurium-induced tetanic fade in the isolated rat muscle.
    Nascimento DC; Serra CS; Oliveira AC
    Basic Clin Pharmacol Toxicol; 2004 Jul; 95(1):9-14. PubMed ID: 15245570
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dose-dependency of pharmacokinetic/pharmacodynamic parameters after intravenous bolus doses of cisatracurium.
    Chen C; Yamaguchi N; Varin F
    Br J Anaesth; 2008 Dec; 101(6):788-97. PubMed ID: 18974056
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A comparative study of the dose-response and time course of recovery of atracurium and rocuronium.
    Xue F; Zhang Y; Liao X; Liu J; An G
    Chin Med J (Engl); 2000 Nov; 113(11):1019-21. PubMed ID: 11776116
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Neuromuscular block.
    Bowman WC
    Br J Pharmacol; 2006 Jan; 147 Suppl 1(Suppl 1):S277-86. PubMed ID: 16402115
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacokinetics, effects on renal function, and potentiation of atracurium-induced neuromuscular blockade after administration of a high dose of gentamicin in isoflurane-anesthetized dogs.
    Martinez EA; Mealey KL; Wooldridge AA; Mercer DE; Cooper J; Slater MR; Hartsfield SM
    Am J Vet Res; 1996 Nov; 57(11):1623-6. PubMed ID: 8915441
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Interactions between suxamethonium and mivacurium or atracurium.
    Kim KS; Na DJ; Chon SU
    Br J Anaesth; 1996 Nov; 77(5):612-6. PubMed ID: 8957977
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Atracurium resistance in a critically Ill patient.
    Tschida SJ; Hoey LL; Nahum A; Vance-Bryan K
    Pharmacotherapy; 1995; 15(4):533-9. PubMed ID: 7479210
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Different magnitude of resistance to non-depolarizing muscle relaxants in dexamethasone-treated rat diaphragm associated with altered acetylcholine receptor expression.
    Chen D; Yang MR; Huang LN; Qiu YW; Li ST
    Genet Mol Res; 2014 Aug; 13(3):5892-900. PubMed ID: 25117347
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.